Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy. [electronic resource]
Producer: 20170925Description: 7-26 p. digitalISSN:- 1757-4684
- Animals
- Antineoplastic Agents -- adverse effects
- Apoptosis
- Breast Neoplasms -- complications
- Cisplatin -- adverse effects
- Deafness -- chemically induced
- Disease Models, Animal
- Hair Cells, Auditory, Inner -- physiology
- Hair Cells, Auditory, Outer -- physiology
- Mice
- Tumor Suppressor Protein p53 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.